RNA-based treatments, CAR-T, and cell therapies are advancing rapidly, forcing a shift in how pharmaceutical companies manage safety risks and regulatory responsibilities.
Join us for a free live webinar hosted by QbD Group to explore how safety and risk management must adapt to support these next-generation therapies. As part of the QbD Group, we’re pleased to extend this invitation to you. Don’t miss the opportunity to gain practical insights from experienced experts.
Date: June 26, 2025
Time: 15:00 CEST
Format: Online webinar
Topic: Pharmacovigilance and Risk Management in Innovative Therapies
This session is ideal for professionals in drug safety, regulatory affairs, and clinical development looking to stay ahead of emerging risks and requirements. During this session, you will learn:
- Strategic approaches to managing risk in innovative treatments
- Unique safety challenges in cell and CAR-T therapies
- The mechanism behind RNA-based technologies and their safety profiles
- Future-facing pharmacovigilance strategies
Secure your spot now and register here: Pharmacovigilance and Risk Management in Innovative Therapies | QbD Group Webinar.